CN116492409A - Tibetan medicinal composition for treating rheumatism - Google Patents
Tibetan medicinal composition for treating rheumatism Download PDFInfo
- Publication number
- CN116492409A CN116492409A CN202211585005.6A CN202211585005A CN116492409A CN 116492409 A CN116492409 A CN 116492409A CN 202211585005 A CN202211585005 A CN 202211585005A CN 116492409 A CN116492409 A CN 116492409A
- Authority
- CN
- China
- Prior art keywords
- parts
- tibetan
- raw materials
- tibetan medicine
- juniper
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 20
- 239000003814 drug Substances 0.000 claims abstract description 76
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 27
- 208000025747 Rheumatic disease Diseases 0.000 claims abstract description 25
- 239000002994 raw material Substances 0.000 claims abstract description 24
- 241000721662 Juniperus Species 0.000 claims abstract description 19
- 244000124209 Crocus sativus Species 0.000 claims abstract description 18
- 235000015655 Crocus sativus Nutrition 0.000 claims abstract description 18
- 241000218671 Ephedra Species 0.000 claims abstract description 18
- 241000208422 Rhododendron Species 0.000 claims abstract description 17
- 235000013974 saffron Nutrition 0.000 claims abstract description 17
- 239000004248 saffron Substances 0.000 claims abstract description 17
- 244000042430 Rhodiola rosea Species 0.000 claims abstract description 16
- 235000003713 Rhodiola rosea Nutrition 0.000 claims abstract description 16
- 210000000582 semen Anatomy 0.000 claims description 14
- 241001075517 Abelmoschus Species 0.000 claims description 13
- 241000218691 Cupressaceae Species 0.000 claims description 12
- 235000003826 Artemisia Nutrition 0.000 claims description 9
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 9
- 244000030166 artemisia Species 0.000 claims description 9
- 235000009052 artemisia Nutrition 0.000 claims description 9
- 235000015784 Artemisia rupestris Nutrition 0.000 claims description 6
- 241001670235 Artemisia rupestris Species 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 239000007938 effervescent tablet Substances 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 4
- 241000972672 Phellodendron Species 0.000 claims description 3
- 235000013939 Malva Nutrition 0.000 claims description 2
- 240000000982 Malva neglecta Species 0.000 claims description 2
- 235000000060 Malva neglecta Nutrition 0.000 claims description 2
- 201000010099 disease Diseases 0.000 abstract description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 15
- 229940079593 drug Drugs 0.000 abstract description 15
- 239000008280 blood Substances 0.000 abstract description 9
- 210000004369 blood Anatomy 0.000 abstract description 9
- 230000017531 blood circulation Effects 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 6
- 238000000034 method Methods 0.000 abstract description 6
- 210000003205 muscle Anatomy 0.000 abstract description 5
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract description 4
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract description 4
- 241000721047 Danaus plexippus Species 0.000 abstract description 4
- 206010061218 Inflammation Diseases 0.000 abstract description 4
- 230000003213 activating effect Effects 0.000 abstract description 4
- 230000003467 diminishing effect Effects 0.000 abstract description 4
- 230000004054 inflammatory process Effects 0.000 abstract description 4
- 210000003734 kidney Anatomy 0.000 abstract description 4
- 241000972673 Phellodendron amurense Species 0.000 abstract description 3
- 208000003251 Pruritus Diseases 0.000 abstract description 3
- 230000002124 endocrine Effects 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 230000001939 inductive effect Effects 0.000 abstract description 3
- 230000007803 itching Effects 0.000 abstract description 3
- 230000004060 metabolic process Effects 0.000 abstract description 3
- 238000005728 strengthening Methods 0.000 abstract description 3
- 230000008961 swelling Effects 0.000 abstract description 3
- 230000002195 synergetic effect Effects 0.000 abstract description 3
- 241001165494 Rhodiola Species 0.000 abstract description 2
- 239000002671 adjuvant Substances 0.000 abstract description 2
- 240000004507 Abelmoschus esculentus Species 0.000 abstract 2
- 235000003069 Artemisia scoparia Nutrition 0.000 abstract 2
- 241001249148 Artemisia scoparia Species 0.000 abstract 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 9
- 208000032843 Hemorrhage Diseases 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 208000017520 skin disease Diseases 0.000 description 5
- 201000005569 Gout Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 206010062575 Muscle contracture Diseases 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 208000006111 contracture Diseases 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 210000001503 joint Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 201000003068 rheumatic fever Diseases 0.000 description 3
- 210000004872 soft tissue Anatomy 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 2
- 241001456553 Chanodichthys dabryi Species 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 206010023232 Joint swelling Diseases 0.000 description 2
- 208000021129 Postpartum disease Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 240000005959 Abelmoschus manihot Species 0.000 description 1
- 235000001075 Abelmoschus manihot Nutrition 0.000 description 1
- 235000001405 Artemisia annua Nutrition 0.000 description 1
- 240000000011 Artemisia annua Species 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241001260012 Bursa Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241001111421 Pannus Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241001313067 Rhododendron prinophyllum Species 0.000 description 1
- 206010039759 Scrotal swelling Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 208000019229 Spleen disease Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010053649 Vascular rupture Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000029162 bladder disease Diseases 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000035474 group of disease Diseases 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000027140 splenic disease Diseases 0.000 description 1
- 201000004595 synovitis Diseases 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 208000026533 urinary bladder disease Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/10—Peat; Amber; Turf; Humus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Tibetan medicine composition mainly used for treating rheumatic diseases, which consists of juniper, rhododendron anthoxylum, artemisia scoparia, tibetan ephedra, phellodendron bark, saffron, rhodiola rosea, amber, cassia seed and okra, wherein five kinds of juniper, rhododendron anthoxylum, artemisia scoparia, tibetan ephedra and phellodendron bark are taken as monarch medicines for clearing heat and detoxicating, reducing swelling and resolving masses, and activating blood circulation to dissipate blood stasis by utilizing the reasonable proportion of the raw materials of the Tibetan medicines and the synergistic effect of the components and the uniqueness of a medicated bath treatment method; saffron and rhodiola root are ministerial drugs, and the monarch drugs are assistant drugs for activating blood and detumescence; amber, cassia seed and okra are taken as adjuvant drugs to jointly achieve the effects of diminishing inflammation and relieving itching, inducing yellow water, tonifying kidney and strengthening yang; the raw materials act together to improve qi and blood circulation of muscle and venation of human body, strengthen metabolism of human body, regulate endocrine and strengthen immunity, and can effectively treat diseases.
Description
Technical Field
The invention relates to the technical field of medicines, in particular to a Tibetan medicine composition for mainly treating rheumatic diseases.
Background
Rheumatic diseases are a group of diseases that affect bones, joints, and surrounding soft tissues, such as muscles, bursa, tendons, fascia, nerves, etc. Including rheumatoid arthritis, gout, ankylosing arthritis, and the like.
In the case of rheumatoid arthritis, rheumatoid arthritis (Rheumatoid arthritis, RA) is a common clinical chronic autoimmune disease, which is commonly seen in middle-aged and elderly people, and is mainly characterized by synovitis and pannus, and is mainly clinically manifested by joint swelling, morning stiffness, difficulty in flexion and extension, pain, tenderness, deformity and the like. The cause and pathogenesis of RA are not clear, so there is no cure therapy, and the treatment of the disease is mainly to control the disease state and relieve the pain of patients. At present, a plurality of traditional Chinese medicines and western medicines are used for treating rheumatoid arthritis. Although the traditional Chinese medicine composition is effective for part of rheumatoid arthritis patients, the treatment method and the medicines are limited, the western medicine treatment side effect is large, and part of patients are not improved or are not obviously improved through the treatment of the traditional Chinese medicine or western medicine system.
On the basis of wide absorption and integration of theories such as traditional Chinese medicine, indian medicine and predatory medicine, a unique medicine system formed by long-term practice has been used for thousands of years. Tibet plateau is the main production place of Tibetan medicine, and 2436 Tibetan medicine resources are provided according to the investigation of related units, wherein 2172 plants, 214 animals and 50 minerals are provided. Tibetan medicine and western medicine are two distinct theoretical systems, and have own characteristics and advantages. The Tibetan medicinal bath is an ancient and effective external treatment method in Tibetan medicine, has long history and rich content, is developed into an independent medicinal treatment branch through thousands of years of clinical practice on the basis of long-term accumulated medical knowledge, and has the characteristics of simplicity, convenience, wide application range and the like. The medicated bath directly acts on the lesion site, takes effect quickly, has no pain, has the functions of curing and preventing diseases, cleaning and health care, and is valued and promoted by medical doctors.
Disclosure of Invention
Therefore, based on the background, the invention improves the prior art, provides a Tibetan medicine composition for mainly treating the rheumatic diseases, prepares a medicated bath product through the Tibetan medicine composition, and safely and effectively treats the rheumatic diseases through Tibetan medicine bath.
The technical scheme provided by the invention is as follows:
a Tibetan medicine composition mainly used for treating rheumatic diseases is composed of the following raw materials:
200-700 parts of juniper, 200-700 parts of rhododendron anthoxylum, 200-700 parts of artemisia rupestris, 200-700 parts of Tibetan ephedra, 200-700 parts of water cypress branch, 50-300 parts of saffron, 100-300 parts of rhodiola rosea, 20-100 parts of amber, 20-100 parts of semen cassiae and 20-100 parts of malva.
Preferably, the Tibetan medicine comprises the following raw materials:
300 parts of juniper, 300 parts of rhododendron anthoxylum, 300 parts of artemisia megaly, 300 parts of Tibetan ephedra, 300 parts of water cypress branch, 100 parts of saffron, 100 parts of rhodiola rosea, 50 parts of amber, 50 parts of semen cassiae and 50 parts of okra.
Preferably, the Tibetan medicine comprises the following raw materials:
650 parts of juniper, 650 parts of rhododendron anthoxylum, 650 parts of artemisia rupestris, 650 parts of ephedra, 650 parts of phellodendron, 200 parts of saffron, 300 parts of rhodiola rosea, 50 parts of amber, 50 parts of semen cassiae and 50 parts of okra.
Preferably, the Tibetan medicine comprises the following raw materials:
500 parts of juniper, 500 parts of rhododendron anthoxylum, 500 parts of artemisia megaseed, 500 parts of Tibetan ephedra, 500 parts of water cypress branch, 100 parts of saffron, 200 parts of rhodiola rosea, 50 parts of amber, 50 parts of semen cassiae and 50 parts of okra.
The invention also provides Tibetan medicine bath powder mainly used for treating the rheumatic diseases, which is prepared from the Tibetan medicine composition mainly used for treating the rheumatic diseases.
The invention also provides a Tibetan medicine bath effervescent tablet for mainly treating the rheumatic diseases, and the preparation raw materials of the Tibetan medicine bath effervescent tablet comprise the Tibetan medicine composition for mainly treating the rheumatic diseases.
The formula of the invention effectively treats the rheumatic diseases (including rheumatic arthritis, rheumatoid arthritis, gout, limb rigidity or contracture and the like) by reasonable proportion of the Tibetan medicine raw materials and by utilizing the synergistic effect of the components and the uniqueness of a medicated bath treatment method.
The pharmacology of the Tibetan medicine principle of the invention is as follows:
juniper (juniper) is provided: fever reducing, lung benefiting, liver and gallbladder. Is mainly used for treating kidney disease, spleen disease, urosis, bladder disease, arthritis, irregular menstruation and the like. Chinese Ben Cao (Tibetan medicine roll).
Rhododendron anthoxylum schinifolium: clearing heat and diminishing inflammation, and tonifying kidney. Mainly treats asthma, edema, physical weakness, water and soil discomfort, dyspepsia, gastroptosis and gastric distention. It is indicated for sore and pestilence by external application. Chinese Ben Cao (Tibetan medicine roll).
Artemisia annua L: hemostasis, detumescence and heat clearing. Can be used for treating hemorrhage, limb joint swelling, carbuncle, furuncle, and trauma caused by various diseases. Chinese Ben Cao (Tibetan medicine roll).
Tibetan ephedra: clearing heat and detoxicating, relieving cough and asthma, promoting urination and detumescence, and stopping bleeding. It is used for treating common cold due to wind-cold, chest distress, asthma, cough, liver heat, red bar heat, spleen heat, etc., and hemorrhage due to vascular rupture. It also has effects in resolving hard mass and eliminating tumor. Ma Huang Huo powder can stop bleeding when being used externally. Chinese Ben Cao (Tibetan medicine roll).
The water cypress branch: clear away heat and toxic materials, relieve cough, dry yellow water. Mainly treats the symptoms of yellow water disease, blood heat, wound heat, immature heat, cough, various drug poisoning, food poisoning, syphilis and the like. Chinese Ben Cao (Tibetan medicine roll).
Saffron crocus: promoting blood circulation, removing blood stasis, cooling blood, removing toxic substance, removing liver fire, improving eyesight, replenishing blood, and stopping bleeding. Is mainly used for treating various liver diseases, blood deficiency, menoxenia and hemorrhage caused by various reasons. Chinese Ben Cao (Tibetan medicine roll).
Rhodiola rosea: promoting blood circulation to remove swelling, clearing lung-heat, relieving cough, relieving fever, relieving pain, invigorating qi and tranquilizing mind. Mainly treats nausea, vomit, purple lips, palm and the like caused by water and soil disuse, general weakness, chest distress, difficult ventilation, physical weakness and insomnia and dreaminess. It can also be used for treating lung heat and pulmonary fatigue. Chinese Ben Cao (Tibetan medicine roll).
Amber: astringing yellow water and healing sore and ulcer. Mainly treats yellow water disease, dragon disease, skin disease, scrotum swelling and other symptoms. Chinese Ben Cao (Tibetan medicine roll).
Semen cassiae: diminishing inflammation, relieving itching, inducing yellow water, tonifying body and strengthening yang. It is indicated for various dermatoses such as suppurative furuncle, carbuncle and furuncle, etc., and also for apoplexy, impotence due to kidney deficiency.
Chinese Ben Cao (Tibetan medicine roll).
Abelmoschus manihot: expelling parasites and astringing yellow water. Is mainly used for treating dermatosis, yellow water disease and leprosy. Chinese Ben Cao (Tibetan medicine roll).
According to the formula, five ingredients of Tibetan medicines are reasonably proportioned, and five ingredients of juniper, rhododendron roseum, artemisia rupestris, ephedra Tibetan and phellodendron bark are taken as monarch medicines by utilizing the synergistic effect of the ingredients and the uniqueness of a medicated bath treatment method, so that the traditional Chinese medicine has the effects of clearing heat and detoxicating, reducing swelling and resolving masses, and activating blood circulation to dissipate blood stasis; saffron and rhodiola root are ministerial drugs, and the monarch drugs are assistant drugs for activating blood and detumescence; amber, cassia seed and okra are taken as adjuvant drugs to jointly achieve the effects of diminishing inflammation and relieving itching, inducing yellow water, tonifying kidney and strengthening yang; the raw materials act together to improve qi and blood circulation of muscle and venation of human body, strengthen metabolism of human body, regulate endocrine and strengthen immunity, not only can treat rheumatic diseases such as rheumatic arthritis, rheumatoid arthritis, gout, limb rigidity or contracture, but also can effectively treat diseases such as hemiplegia, skin diseases, female miscellaneous diseases, postpartum diseases, muscular soft tissues, yellow water disease in joints, humpback and the like.
Detailed Description
Reference now will be made in detail to embodiments of the invention, one or more examples of which are described below. Each example is provided by way of explanation, not limitation, of the invention. Indeed, it will be apparent to those skilled in the art that various modifications and variations can be made to the present invention without departing from the scope or spirit of the invention. For example, features illustrated or described as part of one embodiment can be used on another embodiment to yield still a further embodiment.
Accordingly, it is intended that the present invention cover such modifications and variations as fall within the scope of the appended claims and their equivalents. Other objects, features and aspects of the present invention will be disclosed in or be apparent from the following detailed description. It is to be understood by one of ordinary skill in the art that the present discussion is a description of exemplary embodiments only, and is not intended as limiting the broader aspects of the present invention. The invention is further illustrated below with reference to examples.
Example 1: a Tibetan medicine composition mainly used for treating rheumatic diseases is composed of the following raw materials:
300 parts of juniper, 300 parts of rhododendron anthoxylum, 300 parts of artemisia megaly, 300 parts of Tibetan ephedra, 300 parts of water cypress branch, 100 parts of saffron, 100 parts of rhodiola rosea, 50 parts of amber, 50 parts of semen cassiae and 50 parts of okra.
Example 2: a Tibetan medicine composition mainly used for treating rheumatic diseases is composed of the following raw materials:
the Tibetan medicine comprises the following raw materials:
650 parts of juniper, 650 parts of rhododendron anthoxylum, 650 parts of artemisia rupestris, 650 parts of ephedra, 650 parts of phellodendron, 200 parts of saffron, 300 parts of rhodiola rosea, 50 parts of amber, 50 parts of semen cassiae and 50 parts of okra.
Example 3: a Tibetan medicine composition mainly used for treating rheumatic diseases is composed of the following raw materials:
the Tibetan medicine comprises the following raw materials:
500 parts of juniper, 500 parts of rhododendron anthoxylum, 500 parts of artemisia megaseed, 500 parts of Tibetan ephedra, 500 parts of water cypress branch, 100 parts of saffron, 200 parts of rhodiola rosea, 50 parts of amber, 50 parts of semen cassiae and 50 parts of okra.
Example 4: a Tibetan medicine bath powder mainly used for treating rheumatic diseases is prepared from the following Tibetan medicines:
500 parts of juniper, 500 parts of rhododendron anthoxylum, 500 parts of artemisia megaseed, 500 parts of Tibetan ephedra, 500 parts of water cypress branch, 100 parts of saffron, 200 parts of rhodiola rosea, 50 parts of amber, 50 parts of semen cassiae and 50 parts of okra.
In one example, the Tibetan medicine bath powder comprises the following raw materials in parts by weight:
500g of juniper, 500g of rhododendron anthoxylum, 500g of artemisia megaseed, 500g of Tibetan ephedra, 500g of water cypress branch, 100g of saffron, 200g of rhodiola rosea, 50g of amber, 50g of cassia seed and 50g of okra.
The preparation method comprises the following steps: pulverizing the raw materials, and sieving with 80 mesh sieve.
Example 5: a Tibetan medicine bath effervescent tablet mainly used for treating rheumatic diseases is prepared from the following raw materials:
500 parts of juniper, 500 parts of rhododendron anthoxylum, 500 parts of artemisia megaly, 500 parts of Tibetan ephedra, 500 parts of water cypress branch, 100 parts of saffron, 200 parts of rhodiola rosea, 50 parts of amber, 50 parts of semen cassiae, 50 parts of okra, 600 parts of acid and alkali and 100 parts of polyethylene glycol.
The acid and alkali in the effervescent tablet manufacturing raw material in this embodiment may be citric acid or tartaric acid and sodium carbonate or sodium bicarbonate, and are not limited to the above list in specific implementation.
The preparation method comprises the following steps:
the raw materials are crushed and then pass through a 80-mesh screen, each 30 g of the screened medicinal powder is directly pressed into tablets, and the tablets are used under certain temperature and humidity and are stored in a sealing way.
The application method comprises the following steps:
when in use, 25-40 water Wen Fangru is used for effervescence and dissolution, and then the temperature is proper, the whole body of a human body is soaked in the liquid medicine, under the heat energy of water and the pharmacological action of the medicine, pores of the human body are opened, channels and collaterals are opened, so that the effective components of the medicine are absorbed into the body through skin pores through skin penetration by capillary vessels to quickly reach the affected parts.
And example 4 and example 5 can also be applied to the corresponding parts of external application and foot bath.
The Tibetan medicine composition can obviously improve qi and blood circulation of muscle and veins of a human body, strengthen metabolism of the human body, regulate endocrine, strengthen immunity and the like, can effectively treat rheumatic diseases such as rheumatic arthritis, rheumatoid arthritis, gout, limb rigidity or contracture and the like, and can also effectively treat diseases such as hemiplegia, skin diseases, female miscellaneous diseases, postpartum diseases, yellow water disease in muscle soft tissues and joints, humpback and the like, and has wide application range.
The technical features of the above-described embodiments may be arbitrarily combined, and all possible combinations of the technical features in the above-described embodiments are not described for brevity of description, however, as long as there is no contradiction between the combinations of the technical features, they should be considered as the scope of the description.
Claims (6)
1. A Tibetan medicinal composition for treating rheumatism is characterized in that,
the Tibetan medicine comprises the following raw materials:
200-700 parts of juniper, 200-700 parts of rhododendron anthoxylum, 200-700 parts of artemisia rupestris, 200-700 parts of Tibetan ephedra, 200-700 parts of water cypress branch, 50-300 parts of saffron, 100-300 parts of rhodiola rosea, 20-100 parts of amber, 20-100 parts of semen cassiae and 20-100 parts of malva.
2. A Tibetan medicine composition for treating rheumatic diseases according to claim 1, wherein,
the Tibetan medicine comprises the following raw materials:
300 parts of juniper, 300 parts of rhododendron anthoxylum, 300 parts of artemisia megaly, 300 parts of Tibetan ephedra, 300 parts of water cypress branch, 100 parts of saffron, 100 parts of rhodiola rosea, 50 parts of amber, 50 parts of semen cassiae and 50 parts of okra.
3. A Tibetan medicine composition for treating rheumatic diseases according to claim 1, wherein,
the Tibetan medicine comprises the following raw materials:
650 parts of juniper, 650 parts of rhododendron anthoxylum, 650 parts of artemisia rupestris, 650 parts of ephedra, 650 parts of phellodendron, 200 parts of saffron, 300 parts of rhodiola rosea, 50 parts of amber, 50 parts of semen cassiae and 50 parts of okra.
4. A Tibetan medicine composition for treating rheumatic diseases according to claim 1, wherein,
the Tibetan medicine comprises the following raw materials:
500 parts of juniper, 500 parts of rhododendron anthoxylum, 500 parts of artemisia megaseed, 500 parts of Tibetan ephedra, 500 parts of water cypress branch, 100 parts of saffron, 200 parts of rhodiola rosea, 50 parts of amber, 50 parts of semen cassiae and 50 parts of okra.
5. A Tibetan medicinal bath powder for mainly treating rheumatic diseases, which is characterized by being prepared from the Tibetan medicinal composition for mainly treating the rheumatic diseases according to any one of claims 1 to 4.
6. A Tibetan medicine bath effervescent tablet for mainly treating rheumatic diseases, which is characterized in that the preparation raw materials thereof comprise the Tibetan medicine composition for mainly treating the rheumatic diseases according to any one of claims 1 to 4.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211585005.6A CN116492409A (en) | 2022-12-09 | 2022-12-09 | Tibetan medicinal composition for treating rheumatism |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211585005.6A CN116492409A (en) | 2022-12-09 | 2022-12-09 | Tibetan medicinal composition for treating rheumatism |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116492409A true CN116492409A (en) | 2023-07-28 |
Family
ID=87319027
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211585005.6A Withdrawn CN116492409A (en) | 2022-12-09 | 2022-12-09 | Tibetan medicinal composition for treating rheumatism |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116492409A (en) |
-
2022
- 2022-12-09 CN CN202211585005.6A patent/CN116492409A/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102895365B (en) | External ointment for treating bone injury and orthopedics inflammation | |
| CN106620400A (en) | Wine drug for treating chronic pain damage | |
| CN1977933A (en) | Bone-setting medicine and its use method | |
| CN102526433A (en) | Medicine for treating articular contracture | |
| CN116492409A (en) | Tibetan medicinal composition for treating rheumatism | |
| CN102309646A (en) | Medicament for treating fracture and method for preparation and application | |
| CN101983672A (en) | Medicament for treating cramp | |
| CN105998241A (en) | Chinese patent medicine for treating kidney yang deficiency | |
| CN100571718C (en) | Medicine for dunking tendon | |
| CN102764355B (en) | Traditional Chinese medicine composite for curing femoral head necrosis | |
| CN105456598A (en) | Traditional Chinese medicine composition capable of rapidly setting broken bone | |
| CN110201087A (en) | A kind of externally applied drug for treating shingles zoster | |
| CN104524107A (en) | Chinese patent medicine for wind cold damp impediment symptom | |
| CN104474153A (en) | Medicine used for diminishing inflammation, relieving pain,eliminating blood stasis and promoting tissue regeneration | |
| CN108653588A (en) | External application traditional Chinese medicine for treating orthopedic diseases | |
| CN1253179C (en) | Drug for treating ischemic necrosis of femoral head | |
| CN107308233A (en) | Pharmaceutical composition for treating Bone and joint trauma and soft-tissue trauma | |
| CN103961434B (en) | A kind of fracture surgery Chinese medicine composition | |
| CN1238049C (en) | Rheumatism treating Chinese medicinal paste | |
| CN107823604A (en) | A kind of Chinese medicine composition for treating treating rheumatic ostealgia | |
| CN102078588B (en) | Medicinal composition for treating osteoproliferation and preparation method thereof | |
| CN105963484A (en) | External-use medicinal liquor for treating falling injuries | |
| CN104922560B (en) | A kind of joint spirit Chinese medicine composition and preparation method thereof | |
| CN103251851B (en) | Internal and external traditional Chinese medicine formulation for treating rheumatic and rheumatoid diseases | |
| CN111529584A (en) | A Chinese medicinal composition for treating fracture, arthritis and acute and chronic soft tissue injury, and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20230728 |